Oncology Institute, Inc. TOI 深 沪
等待开盘 06-24 09:30:00 美东时间
5.03
+0.020
+0.40%
华盛通- 最 高5.19
- 今 开4.90
- 成交量 115.54万股
- 最 低 4.90
- 昨 收 5.01
- 总市值 5.03亿
- 52周最高 5.575
- 市盈率 静 --
- 换手率 1.16%
- 52周最低 2.32
- 委 比 -24.69%
- 总股本 9998.29万
- 历史最高 12.66
- 量 比 0.65
- 振 幅 5.79%
- 历史最低 0.1253
- 每 手 1
- 风险率 0.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗维持美光科技"买入"评级！目标价从840美元升至1200美元
今日重点评级关注：Chardan Capital：维持SAB Biotherapeutics"买入"评级，目标价从14美元升至16美元；Northland Capital Markets：维持Applied Digital"跑赢大市"评级，目标价从56美元升至82美元
06-18 19:08
Needham Maintains Buy on Oncology Institute, Raises Price Target to $7
Needham analyst Matthew Shea maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $5 to $7.
06-17 18:17
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
Shares of healthcare providers and services companies are trading higher amid sympathy with UnitedHealth Group after B of A Securities upgraded the stock and raised its price target, in addition to Morgan Stanley's raised price target by approximately 13%.
Shares of healthcare providers and services companies are trading higher amid s...
06-05 01:23
美股牛股 | Eightco获Bitmine、木头姐巨额注资！稀土概念美国锑业单日大涨逾19%
Eightco单日飙涨34%，获Bitmine、木头姐巨额注资！稀土概念美国锑业大涨逾19%，五角大楼签署9600万美元稀土供应框架>>
03-17 18:53
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during ...
03-13 05:05
The Oncology Institute shares are trading higher after the company reported better-than-expected Q4 financial results.
The Oncology Institute shares are trading higher after the company reported bet...
03-13 04:43
Oncology Institute Affirms FY2026 Sales Guidance of $630.000M-$650.000M.
Oncology Institute (NASDAQ:TOI) affirms FY2026 sales outlook from $630.000 million-$650.000 million to $630.000 million-$650.000 million.
03-13 04:08
